Legis Daily

Second Chance for Moms Act

USA119th CongressHR-796| House 
| Updated: 1/28/2025
Mary E. Miller

Mary E. Miller

Republican Representative

Illinois

Cosponsors (13)
Sheri Biggs (Republican)Barry Moore (Republican)Andy Harris (Republican)Claudia Tenney (Republican)Andrew Ogles (Republican)Daniel Webster (Republican)Gary J. Palmer (Republican)Riley M. Moore (Republican)John W. Rose (Republican)Randy K. Sr. Weber (Republican)Mark Harris (Republican)Andrew S. Clyde (Republican)Brian Babin (Republican)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This bill, titled the "Second Chance for Moms Act of 2025," aims to inform women about the potential to counteract the effects of mifepristone. It mandates a conspicuous warning label on mifepristone packaging, advising that medical evidence suggests its abortifacient effects can be counteracted by natural progesterone, which may increase the chance of fetal survival. The label would also note the American Society for Reproductive Medicine's determination that natural progesterone is safe in the first trimester. Furthermore, the legislation establishes a toll-free hotline , operating 24/7, to provide support and information to women seeking to reverse mifepristone's effects. This hotline would exclusively refer callers to healthcare providers specializing in abortion pill reversal services.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 118-7823
Second Chance for Moms Act
Jan 28, 2025
Introduced in House
Jan 28, 2025
Referred to the House Committee on Energy and Commerce.
  • Bill from Previous Congress

    HR 118-7823
    Second Chance for Moms Act


  • January 28, 2025
    Introduced in House


  • January 28, 2025
    Referred to the House Committee on Energy and Commerce.

Health

AbortionConsumer affairsPrescription drugsSex and reproductive healthTelephone and wireless communicationWomen's health

Second Chance for Moms Act

USA119th CongressHR-796| House 
| Updated: 1/28/2025
This bill, titled the "Second Chance for Moms Act of 2025," aims to inform women about the potential to counteract the effects of mifepristone. It mandates a conspicuous warning label on mifepristone packaging, advising that medical evidence suggests its abortifacient effects can be counteracted by natural progesterone, which may increase the chance of fetal survival. The label would also note the American Society for Reproductive Medicine's determination that natural progesterone is safe in the first trimester. Furthermore, the legislation establishes a toll-free hotline , operating 24/7, to provide support and information to women seeking to reverse mifepristone's effects. This hotline would exclusively refer callers to healthcare providers specializing in abortion pill reversal services.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 118-7823
Second Chance for Moms Act
Jan 28, 2025
Introduced in House
Jan 28, 2025
Referred to the House Committee on Energy and Commerce.
  • Bill from Previous Congress

    HR 118-7823
    Second Chance for Moms Act


  • January 28, 2025
    Introduced in House


  • January 28, 2025
    Referred to the House Committee on Energy and Commerce.
Mary E. Miller

Mary E. Miller

Republican Representative

Illinois

Cosponsors (13)
Sheri Biggs (Republican)Barry Moore (Republican)Andy Harris (Republican)Claudia Tenney (Republican)Andrew Ogles (Republican)Daniel Webster (Republican)Gary J. Palmer (Republican)Riley M. Moore (Republican)John W. Rose (Republican)Randy K. Sr. Weber (Republican)Mark Harris (Republican)Andrew S. Clyde (Republican)Brian Babin (Republican)

Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
AbortionConsumer affairsPrescription drugsSex and reproductive healthTelephone and wireless communicationWomen's health